TY - JOUR AB - Exosomes are small vesicles with a diameter of ~40‑100 nm that are secreted by the majority of endogenous cells under normal and pathological conditions. They contain abundant proteins, lipids, microRNAs, and biomolecules such as signal transduction molecules, adhesion factors and cytoskeletal proteins, and play an important role in exchanging materials and transmitting information between cells. Recent studies have shown that exosomes are involved in the pathophysiology of leukaemia by affecting the bone marrow microenvironment, apoptosis, tumour angiogenesis, immune escape and chemotherapy resistance. Furthermore, exosomes are potential biomarkers and drug carriers for leukaemia, impacting the diagnosis and treatment of leukaemia. The present study describes the biogenesis and general characteristics of exosomes, and then highlight the emerging roles of exosomes in different types of leukaemia. Finally, the value of clinical application of exosomes as biomarkers and drug carriers is discussed with the aim to provide novel strategies for the treatment of leukaemia. AD - Department of Hematology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong 261031, P.R. China School of Clinical Medicine, Weifang Medical University, Weifang, Shandong 261053, P.R. China Department of Immunology, Weifang Medical University, Weifang, Shandong 261053, P.R. China AU - Chen,Lei AU - Xie,Ting AU - Wei,Bing AU - Di,Da-Lin DA - 2023/03/01 DO - 10.3892/etm.2023.11825 IS - 3 JO - Exp Ther Med KW - exosomes leukaemia biomarkers vaccine development drug carriers PY - 2023 SN - 1792-0981 1792-1015 SP - 126 ST - Tumour‑derived exosomes and their emerging roles in leukaemia (Review) T2 - Experimental and Therapeutic Medicine TI - Tumour‑derived exosomes and their emerging roles in leukaemia (Review) UR - https://doi.org/10.3892/etm.2023.11825 VL - 25 ER -